Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      Homepharmaceutical company

      pharmaceutical company

      Pfizer requests that the FDA approve Covid booster injections that target omicron BA.5 for individuals aged 12 and up
      Investing News

      Pfizer requests that the FDA approve Covid booster injections that target omicron BA.5 for individuals aged 12 and up

      August 22, 2022
      Quest Diagnostics Finds The Missing Piece Of The New Alzheimer’s Therapy Package
      Uncategorized

      Quest Diagnostics Finds The Missing Piece Of The New Alzheimer’s Therapy Package

      July 6, 2022
      Nirvana Life Sciences Inc. Announces License for a Delivery System for Psychedelic APIs
      Other

      Nirvana Life Sciences Inc. Announces License for a Delivery System for Psychedelic APIs

      July 6, 2022
      Compugen to Present at Upcoming Industry Conferences
      Health

      Compugen to Present at Upcoming Industry Conferences

      June 27, 2022
      « 1 2 3 4

       

      LATEST NEWS

      • Investing News Goldman Sachs Q1 2026 Earnings Insights
      • Investing News Earnings Season Kicks Off with Key Reports
      • Investing News TSMC Reports Q1 Record Revenue
      • Investing News Uniqlo’s Impact on Retail Market
      • Investing News Levi Strauss Q1 2026 Earnings Report

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026